The global CMO/CDMO Market was valued at USD 20.9 billion in 2023 and is projected to reach USD 51 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.4% over the forecast period from 2024 to 2032. The increasing demand for outsourced pharmaceutical and biopharmaceutical manufacturing, along with technological advancements in drug development, is driving significant growth in the CMO/CDMO market.
Market Overview
CMOs and CDMOs provide pharmaceutical and biopharmaceutical companies with outsourcing services that range from drug development to manufacturing. These organizations are crucial for accelerating time-to-market, reducing production costs, and ensuring high-quality products. The growing trend of pharmaceutical companies outsourcing non-core operations, combined with the rise of biopharmaceuticals and complex drug formulations, is expected to boost the demand for CMO/CDMO services over the forecast period.
Get A Free Sample Report on CMO/CDMO Market @ https://www.snsinsider.com/sample-request/1289
Key Market Drivers
Increasing Demand for Outsourced Manufacturing: The rising complexity of drug development, coupled with the need to minimize manufacturing costs, is driving pharmaceutical and biotech companies to outsource production to CMOs and CDMOs. Outsourcing allows these companies to focus on their core competencies, such as R&D, while leveraging the expertise of specialized contract manufacturers.
Growth in Biopharmaceuticals and Biosimilars: The expanding biopharmaceutical sector, including the production of biologics and biosimilars, is a key factor driving the CMO/CDMO market. As biologics require complex manufacturing processes, pharmaceutical companies are increasingly partnering with CDMOs to ensure efficient production and regulatory compliance.
Rising Investment in Drug Development and Innovation: The global rise in investment in drug development, especially for personalized medicine, cell and gene therapies, and novel drug delivery systems, is contributing to the growth of the CMO/CDMO market. These organizations are well-equipped with state-of-the-art facilities to meet the high demand for innovative drugs.
Regulatory Expertise and Global Expansion: CMO/CDMOs offer significant regulatory expertise, helping companies navigate complex global regulations and achieve faster approvals. Moreover, the global expansion of pharmaceutical manufacturing capabilities is enhancing market growth, particularly in regions like Asia-Pacific and Latin America.
KEY MARKET SEGMENTATION:
On the Basis of Service:
Contract Development
R&D Services
Clinical Trail Services
Pre-Formulation Studies
Others
Contract Manufacturing
API Manufacturing
Finished Dosage Manufacturing
Injectable Drug Manufacturing
Tablet & Capsule Manufacturing
Liquid Manufacturing
Topical Drug Manufacturing
On the Basis of End User:
Large Pharma Companies
Mid-Sized Pharma Companies
Biotechnology Companies
Others
KEY PLAYERS:
Some of the major key players are as follows: Piramal Pharma Solutions, Samsung Biologics, Eurofins Scientific, mAbxience, Lonza, CoreRx, AXXELENT, Laurus Synthesis, KBI Biopharma., Sai Life Sciences, Idifarma, QuayPharma, BDR Pharmaceuticals Internationals Pvt. Ltd., HIKAL Ltd.
Conclusion
The CMO/CDMO market is expected to experience robust growth over the forecast period, driven by the rising demand for outsourced manufacturing services, advancements in biopharmaceuticals, and the need for cost-efficient production solutions. As pharmaceutical companies continue to focus on innovation and speed-to-market, the market presents significant opportunities for key players.
Make an inquiry on the CMO/CDMO Market Report @ https://www.snsinsider.com/enquiry/1289
Table of Contents
1. Introduction
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global CMO/CDMO Market Segmentation, By Service
9. Global CMO/CDMO Market Segmentation, By End User
10. Regional Analysis
11. Company Profiles
12. Competitive Landscape
13. Conclusion
Buy a Single-User PDF of CMO/CDMO Market @ https://www.snsinsider.com/checkout/1289
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
